Other languages NATCO Pharma Limited

Equities

NATCOPHARM

INE987B01026

Market Closed - NSE India S.E. Other stock markets 12:43:49 03/05/2024 BST			5-day change	1st Jan Change
1,034 ^INR	+2.27%		+0.60%	+27.45%

04-09	Natco Pharma Gets US FDA Warning Letter after Inspection of Kothur, India Unit	MT
03-27	NATCO Pharma Limited Announces Board Appointments	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Natco Pharma Gets US FDA Warning Letter after Inspection of Kothur, India Unit	04-09
NATCO Pharma Limited Announces Board Appointments	03-27
INDIA STOCKS-Indian shares erase early gains, weighed down by IT stocks	02-19
NATCO Pharma Limited Revises Earnings Guidance for the Fiscal Year 2024	02-15
Corporate Action-Board Approves Third Interim Dividend for the Financial Year 2023-24, Payable on 4 March 2024	02-14
NATCO Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-14
Floods Disrupt Operations of Natco Pharma's Plant in Tamil Nadu, India	12-07
Natco Pharma's Consolidated Profit Soars in Fiscal Q2, Declares Second Interim Dividend	11-14
NATCO Pharma Limited Declares Second Interim Dividend for the Financial Year 2023-24, Payable on 1 December, 2023	11-14
NATCO Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-14
US FDA Clears Natco Pharma's Pharmacovigilance Department in Hyderabad, India	11-02
Indian Equities End Higher for Sixth Straight Day, Buoyed by Banking, Public Sector Enterprises	08/09/23
Natco Pharma, Three Others Face Antitrust Violation Raps in US; Natco Pharma Shares Drop 3%	08/09/23
Bristol Myers accused of illegal tactics to keep Pomalyst monopoly in lawsuit	06/09/23
Indian shares set to open flat on caution ahead of GDP data	31/08/23
Natco Pharma to Form UK Arm	09/08/23
NATCO Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	09/08/23
NATCO Pharma Limited Declares Interim Dividend for the Financial Year 2023-24	09/08/23
Natco Pharma Seeks US FDA Approval for Bladder Cancer Drug	26/07/23
Natco Pharma Gets US FDA's Final Approval for Generic Colorectal Cancer Drug	16/06/23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages NATCO Pharma Limited

Equities

NATCOPHARM

INE987B01026

Other languages

Filters